Home
E-submission
Sitemap
Contact us
ABOUT
Aims and scope
About the journal
About the society
Editorial board
Managing team
Best practice
Metrics
Contact us
ARTICLE & TOPICS
Article Category
Editorial
Review
Original article
Case report
Images of the issue
Letters to the editor
Others
Browse all articles >
TOPICS
IBD
Microbiota
Tumor
Endoscopy
Functional disorder
Infection
Miscellaneous
Browse all articles >
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Most view
Most download
Most cited
Hot topic
Funded articles
Search
Author index
EDITORIAL POLICY
Research & publication ethics
Peer review policy
Copyright & license
Others
- Data sharing policy
- Archiving policy
- Preprint policy
- Advertising policy
- CrossMark policy
FOR CONTRIBUTORS
FOR AUTHORS
Instructions to authors
Review flow
Article processing charge
Author’s checklist
Copyright transfer agreement
E-submission
FOR REVIEWERS
Instructions to reviewers
How to become a reviewer?
FOR READERS
Open access
Subscription information
TOC alerts
How to cite this journal?
Permission request
Search
Intest Res Search
CLOSE
Search
Page Path
HOME
Search
IBD
Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, Kanami Sugimoto, Yuya Imai, Seiji Yokoyama, Yasuo Suzuki
Intest Res.
2022;20(3):329-341.
Published online August 4, 2021
DOI:
https://doi.org/10.5217/ir.2021.00032
Web of Science 3
Crossref 4
Full text
PubReader
ePub
PDF
Supplementary Material
Inflammatory bowel diseases
Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study
Toshifumi Hibi, Satoshi Motoya, Toshifumi Ashida, Souken Sai, Yukinori Sameshima, Shiro Nakamura, Atsuo Maemoto, Masahiro Nii, Barbara A Sullivan, Robert A. Gasser Jr, Yasuo Suzuki
Intest Res.
2019;17(3):375-386.
Published online February 12, 2019
DOI:
https://doi.org/10.5217/ir.2018.00141
Web of Science 15
Crossref 14
Full text
PubReader
ePub
PDF
IBD
Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study
Shiro Nakamura, Hirotsugu Imaeda, Hiroki Nishikawa, Masaki Iimuro, Minoru Matsuura, Hideo Oka, Junsuke Oku, Takako Miyazaki, Hirohito Honda, Kenji Watanabe, Hiroshi Nakase, Akira Andoh
Intest Res.
2018;16(4):554-562.
Published online October 10, 2018
DOI:
https://doi.org/10.5217/ir.2018.00027
Web of Science 4
Crossref 3
Full text
PubReader
ePub
PDF
Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
Tadakazu Hisamatsu, Reiko Kunisaki, Shiro Nakamura, Tomoyuki Tsujikawa, Fumihito Hirai, Hiroshi Nakase, Kenji Watanabe, Kaoru Yokoyama, Masakazu Nagahori, Takanori Kanai, Makoto Naganuma, Hirofumi Michimae, Akira Andoh, Akihiro Yamada, Tadashi Yokoyama, Noriko Kamata, Shinji Tanaka, Yasuo Suzuki, Toshifumi Hibi, Mamoru Watanabe,
Intest Res.
2018;16(3):494-498.
Published online July 27, 2018
DOI:
https://doi.org/10.5217/ir.2018.16.3.494
Web of Science 17
Crossref 17
Full text
PubReader
ePub
PDF
Supplementary Material
Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries
Taku Kobayashi, Tadakazu Hisamatsu, Yasuo Suzuki, Haruhiko Ogata, Akira Andoh, Toshimitsu Araki, Ryota Hokari, Hideki Iijima, Hiroki Ikeuchi, Yoh Ishiguro, Shingo Kato, Reiko Kunisaki, Takayuki Matsumoto, Satoshi Motoya, Masakazu Nagahori, Shiro Nakamura, Hiroshi Nakase, Tomoyuki Tsujikawa, Makoto Sasaki, Kaoru Yokoyama, Naoki Yoshimura, Kenji Watanabe, Miiko Katafuchi, Mamoru Watanabe, Toshifumi Hibi
Intest Res.
2018;16(2):168-177.
Published online April 30, 2018
DOI:
https://doi.org/10.5217/ir.2018.16.2.168
Web of Science 8
Crossref 8
Full text
PubReader
ePub
PDF
NUDT15
,
FTO
, and
RUNX1
genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases
Toshiyuki Sato, Tetsuya Takagawa, Yoichi Kakuta, Akihiro Nishio, Mikio Kawai, Koji Kamikozuru, Yoko Yokoyama, Yuko Kita, Takako Miyazaki, Masaki Iimuro, Nobuyuki Hida, Kazutoshi Hori, Hiroki Ikeuchi, Shiro Nakamura
Intest Res.
2017;15(3):328-337.
Published online June 12, 2017
DOI:
https://doi.org/10.5217/ir.2017.15.3.328
Web of Science 34
Crossref 31
Full text
PubReader
ePub
PDF
1
Journal Impact Factor 4.9
ABOUT
Aims and scope
About the journal
About the society
Editorial board
Managing team
Best practice
Metrics
Contact us
ARTICLE & TOPICS
Article Category
Editorial
Review
Original article
Case report
Images of the issue
Letters to the editor
Others
Browse all articles >
TOPICS
IBD
Microbiota
Tumor
Endoscopy
Functional disorder
Infection
Miscellaneous
Browse all articles >
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Most view
Most download
Most cited
Hot topic
Funded articles
Search
Author index
EDITORIAL POLICY
Research & publication ethics
Peer review policy
Copyright & license
Others
- Data sharing policy
- Archiving policy
- Preprint policy
- Advertising policy
- CrossMark policy
AUTHOR INFORMATION
FOR AUTHORS
Instructions to authors
Review flow
Article processing charge
Author’s checklist
Copyright transfer agreement
E-submission
FOR REVIEWERS
Instructions to reviewers
How to become a reviewer?